Glucocorticoid-induced adrenal insufficiency.
Krasner
A S
AS
Division of Endocrinology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. alan_s_krasner@groton.pfizer.com
D000309:Adrenal Insufficiency / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D013312:Stress, Physiological; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis; D013514:Surgical Procedures, Operative; D014221:Triamcinolone / Q000009:adverse effects / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014221:Triamcinolone; D011241:Prednisone; D006854:Hydrocortisone